Godson Oguchi

2.8k total citations
5 papers, 125 citations indexed

About

Godson Oguchi is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Godson Oguchi has authored 5 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Virology and 1 paper in Molecular Biology. Recurrent topics in Godson Oguchi's work include HIV Research and Treatment (2 papers), HIV/AIDS drug development and treatment (2 papers) and Hepatitis C virus research (1 paper). Godson Oguchi is often cited by papers focused on HIV Research and Treatment (2 papers), HIV/AIDS drug development and treatment (2 papers) and Hepatitis C virus research (1 paper). Godson Oguchi collaborates with scholars based in United States, France and Germany. Godson Oguchi's co-authors include Andrew Cheng, Catherine Creticos, Jürgen K. Rockstroh, Hal Martin, Peter Ruane, Ellen Koenig, Edwin DeJesus, Ya-Pei Liu, Eric S. Daar and Gordon Crofoot and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet HIV and Open Forum Infectious Diseases.

In The Last Decade

Godson Oguchi

5 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Godson Oguchi United States	3	122	84	62	12	11	5	125
Natasja van Holten Netherlands	3	132 1.1×	88 1.0×	44 0.7×	14 1.2×	26 2.4×	4	143
Lizette Santiago United States	4	102 0.8×	71 0.8×	44 0.7×	6 0.5×	20 1.8×	4	113
Tanaka Muzenda United States	2	82 0.7×	70 0.8×	38 0.6×	4 0.3×	25 2.3×	2	102
Dannae Brown United States	6	152 1.2×	118 1.4×	26 0.4×	5 0.4×	32 2.9×	8	158
Arvind Kaimal Uganda	4	137 1.1×	104 1.2×	15 0.2×	7 0.6×	32 2.9×	6	152
Kenneth Sutton United States	5	75 0.6×	64 0.8×	14 0.2×	4 0.3×	11 1.0×	15	87
Havilland Campbell United States	2	161 1.3×	128 1.5×	30 0.5×	22 1.8×	17 1.5×	4	173
Anthony Scarsella United States	6	127 1.0×	97 1.2×	40 0.6×	6 0.5×	33 3.0×	7	153
Pedro Cahn Argentina	4	154 1.3×	126 1.5×	35 0.6×	3 0.3×	17 1.5×	5	169
Johannes Lombaard United States	2	106 0.9×	85 1.0×	20 0.3×	2 0.2×	19 1.7×	4	110

Countries citing papers authored by Godson Oguchi

Since Specialization

Citations

This map shows the geographic impact of Godson Oguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Godson Oguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Godson Oguchi more than expected).

Fields of papers citing papers by Godson Oguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Godson Oguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Godson Oguchi. The network helps show where Godson Oguchi may publish in the future.

Co-authorship network of co-authors of Godson Oguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Godson Oguchi. A scholar is included among the top collaborators of Godson Oguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Godson Oguchi. Godson Oguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Berhe, Mezgebe, et al.. (2024). Activité antivirale, tolérance et pharmacocinétique du GS-1720, un nouvel INI oral hebdomadaire. 3(2). S139–S139. 1 indexed citations

2.

Sims, Matthew, Michael Silverman, Thomas Louie, et al.. (2023). Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection. SHILAP Revista de lepidopterología. 3(S2). s5–s5. 1 indexed citations

3.

Daar, Eric S., Edwin DeJesus, Peter Ruane, et al.. (2018). Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. The Lancet HIV. 5(7). e347–e356. 117 indexed citations

4.

Oguchi, Godson, et al.. (2018). 2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ). Open Forum Infectious Diseases. 5(suppl_1). S708–S708. 2 indexed citations

5.

Daar, Eric S., Edwin DeJesus, Peter Ruane, et al.. (2017). Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results. Open Forum Infectious Diseases. 4(suppl_1). S735–S735. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact